CN105708999A - Improved externally-applied traditional Chinese medicine for treating knee joint osteoarthritis - Google Patents
Improved externally-applied traditional Chinese medicine for treating knee joint osteoarthritis Download PDFInfo
- Publication number
- CN105708999A CN105708999A CN201610170631.7A CN201610170631A CN105708999A CN 105708999 A CN105708999 A CN 105708999A CN 201610170631 A CN201610170631 A CN 201610170631A CN 105708999 A CN105708999 A CN 105708999A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- knee joint
- traditional chinese
- processed
- medicine external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 89
- 210000000629 knee joint Anatomy 0.000 title claims abstract description 44
- 230000001976 improved effect Effects 0.000 title claims abstract description 11
- 201000008482 osteoarthritis Diseases 0.000 title abstract description 17
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 15
- 241000628997 Flos Species 0.000 claims abstract description 15
- 239000004863 Frankincense Substances 0.000 claims abstract description 15
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 15
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 206010003246 arthritis Diseases 0.000 claims description 34
- 229940079593 drug Drugs 0.000 claims description 26
- 230000006872 improvement Effects 0.000 claims description 21
- 241000717739 Boswellia sacra Species 0.000 claims description 14
- 241001057584 Myrrha Species 0.000 claims description 14
- 241000237636 Pheretima Species 0.000 claims description 14
- 241000131808 Scolopendra Species 0.000 claims description 14
- 241000522620 Scorpio Species 0.000 claims description 14
- 239000009286 sanguis draxonis Substances 0.000 claims description 14
- 239000009490 scorpio Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002674 ointment Substances 0.000 claims description 8
- 238000013461 design Methods 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 4
- 230000003203 everyday effect Effects 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000005498 polishing Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- -1 reflux Substances 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 229940099259 vaseline Drugs 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 16
- 238000002560 therapeutic procedure Methods 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000006264 Asimina triloba Nutrition 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000725145 Homalomena Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 241000208682 Liquidambar Species 0.000 abstract 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 230000036407 pain Effects 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 208000025747 Rheumatic disease Diseases 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000000552 rheumatic effect Effects 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 208000014674 injury Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides an improved externally-applied traditional Chinese medicine for treating knee joint osteoarthritis, and belongs to the technical field of traditional Chinese medicine preparations. The improved externally-applied traditional Chinese medicine for treating the knee joint osteoarthritis is prepared from 25 g of suberect spatholobus stems, 10 g of obscured homalomena rhizomes, 50 g of dragon's blood, 25 g of garden balsam stems, 25 g of beautiful sweetgum fruit, 30 g of pawpaws, 25 g of common clubmoss herb, 25 g of bark of eucommia, 25 g of chuanxiong rhizomes, 18 g of prepared frankincense, 18 g of prepared myrrh, 13 g of centipedes, 10 g of lumbricus, 9 g of scorpions, 25 g of flos carthami, 13 g of borneol, 20 g of Chinese taxillus twigs, 18 g of panax notoginseng and 20 g of bidentate achyranthes roots. The medicine has a significant curative effect on treating osteoarthritis. It is proved through clinical trials that the medicine has the advantages that the medicine efficacy is stable, the osteoarthritis is not prone to relapse, the clinical curative effect is significant, the therapy is simple, convenient, rapid, safe, reliable and free of side effect, the diagnosis and treatment cost is low, and the medicine is suitable for being introduced and popularized by primary care institutions and can be accepted by patients with the knee joint osteoarthritis.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation, particularly relate to the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement.
Background technology
Knee joint osseous arthritis (osteoarthritis, OA) refers to the chronic osteoarthrosis illness of one caused due to knee cartilage degeneration, hyperosteogeny, is also called gonarthrosis, degenerative osteoarthritis and osseous arthritis etc..Primary disease is multiple is born in middle-aged and elderly people, it is possible to adolescence occurs；Can unilateral fall ill, it is possible to bilateral is fallen ill.Knee joint OA refers to the thin-skinned ostosis constitutional of knee joint endoprosthesis or secondary degeneration and structure disturbance, strip off with subchondral bone matter hypertrophy, cartilage, so that joint is destroyed gradually, deformity, final a kind of degenerative disease that knee joint disorders occurs, general long-term posture is bad, bear a heavy burden firmly, overweight, chronic strain is all the cause of disease causing knee joint OA, the misery that OA causes and the disabled life quality seriously damaging patient, and have become as one of serious social economical burden that current social faces.Along with China's population steps into the aging epoch, it is contemplated that the sickness rate of OA also can be more and more higher.The purpose of osteoarthritis treatment is alleviation arthralgia, improves function and rebuild impaired cartilage and bone structure, but at present from doctor trained in Western medicine, still lack the reliable medicine that can achieve the goal, even if only by relief of symptoms, improving for the purpose of function, also lack the non-operative treatment of better efficacy, less adverse effect.
At present, the conventional western medicine of osteoarthritis is to control acute attack, and Long-term taking medicine is main, and toxic and side effects is relatively obvious, and patient is difficult to long-term tolerance, and lacks desirable therapy and medicine.Chinese medicine primary disease has that method is many, effective, toxicity is little, can characteristic and the advantage such as prolonged application, currently become a focus of clinical research.Wherein, with " medicine of external treatment, the i.e. medicine for the treatment of by oral administration of medicines；The reason of external treatment, the i.e. reason for the treatment of by oral administration of medicines " for theoretical basis Chinese medicine external treatment treatment knee osteoarthritis in have rich experience.The traditional Chinese medical science thinks that external therapy of Chinese herb is in affected part, it is possible to by through the cave one relevant approach of internal organs, acting on each system internal, and play the Accommodation of multisystem, multiple organ, too many levels.Modern study shows, external treatment medicine, except being directly entered blood circulation and playing therapeutical effect, also has and adjusts the effect such as system organization organ dysfunction and body's immunity, to play its indirectly therapeutical effect.Owing to Chinese medicine external treatment route of administration is simple and easy to do, it is possible to avoid digestive tract to be administered the stimulation caused, reduce poisonous side effect of medicine, it is easy to be accepted by patients, therefore there is good potentiality to be exploited.It was verified that treat knee joint osseous arthritis outside Chinese medicine to have fully demonstrated therapeutic features and the advantage of Chinese medicine.Now, in view of its sickness rate is high, for knee osteoarthritis more demand anxious a kind of curative effect of exploitation to be studied Chinese medicine preparation certainly in clinic.
Therefore, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis inventing a kind of improvement seems very necessary.
Summary of the invention
In order to solve prior art Problems existing, the Chinese medicine of abundant treatment knee joint osseous arthritis, meanwhile, more targeted also for clinical treatment primary disease, the invention provides the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement.The Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of described improvement selects acupoint application of Chinese herb, is conducted by meridians, QI and blood regulating, expelling wind and removing dampness, makes channels and collaterals dredging, and muscle is foster to some extent, and bone is raw to some extent, thus reach to ease the pain, the purpose of cure diseases.The Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug of following parts by weight: Caulis Spatholobi 20g～25g, Rhizoma Homalomenae 5g～10g, Sanguis Draxonis 40g～50g, Herba speranskiae tuberculatae 20g～25g, Fructus Liquidambaris 20g～25g, Fructus Chaenomelis 25g～30g, Herba Lycopodii 20g～25g, Cortex Eucommiae 20g～25g, Rhizoma Chuanxiong 20g～25g, Olibanum (processed) 15g～18g, Myrrha (processed) 15g～18g, Scolopendra 10g～13g, Pheretima 5g～10g, Scorpio 5g～9g, Flos Carthami 20g～25g, Borneolum Syntheticum 10g～13g, Herba Taxilli 15g～20g, Radix Notoginseng 15g～18g and Radix Achyranthis Bidentatae 15g～20g.
Preferably, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of described improvement includes the crude drug of following parts by weight: Caulis Spatholobi 25g～30g, Rhizoma Homalomenae 10g～15g, Sanguis Draxonis 50g～60g, Herba speranskiae tuberculatae 25g～30g, Fructus Liquidambaris 25g～30g, Fructus Chaenomelis 30g～35g, Herba Lycopodii 25g～30g, Cortex Eucommiae 25g～30g, Rhizoma Chuanxiong 25g～30g, Olibanum (processed) 18g～25g, Myrrha (processed) 18g～25g, Scolopendra 13g～15g, Pheretima 10g～15g, Scorpio 9g～15g, Flos Carthami 25g～30g, Borneolum Syntheticum 13g～15g, Herba Taxilli 20g～30g, Radix Notoginseng 18g～25g and Radix Achyranthis Bidentatae 20g～30g.
Preferably, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight: Caulis Spatholobi 25g, Rhizoma Homalomenae 10g, Sanguis Draxonis 50g, Herba speranskiae tuberculatae 25g, Fructus Liquidambaris 25g, Fructus Chaenomelis 30g, Herba Lycopodii 25g, Cortex Eucommiae 25g, Rhizoma Chuanxiong 25g, Olibanum (processed) 18g, Myrrha (processed) 18g, Scolopendra 13g, Pheretima 10g, Scorpio 9g, Flos Carthami 25g, Borneolum Syntheticum 13g, Herba Taxilli 20g, Radix Notoginseng 18g and Radix Achyranthis Bidentatae 20g.
Preferably, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight and is: Caulis Spatholobi 20g, Rhizoma Homalomenae 5g, Sanguis Draxonis 40g, Herba speranskiae tuberculatae 20g, Fructus Liquidambaris 20g, Fructus Chaenomelis 25g, Herba Lycopodii 20g, Cortex Eucommiae 20g, Rhizoma Chuanxiong 20g, Olibanum (processed) 15g, Myrrha (processed) 15g, Scolopendra 10g, Pheretima 5g, Scorpio 5g, Flos Carthami 20g, Borneolum Syntheticum 10g, Herba Taxilli 15g, Radix Notoginseng 15g and Radix Achyranthis Bidentatae 15g.
Preferably, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight and is: Caulis Spatholobi 30g, Rhizoma Homalomenae 15g, Sanguis Draxonis 60g, Herba speranskiae tuberculatae 30g, Fructus Liquidambaris 30g, Fructus Chaenomelis 35g, Herba Lycopodii 30g, Cortex Eucommiae 30g, Rhizoma Chuanxiong 30g, Olibanum (processed) 25g, Myrrha (processed) 25g, Scolopendra 15g, Pheretima 15g, Scorpio 15g, Flos Carthami 30g, Borneolum Syntheticum 15g, Herba Taxilli 30g, Radix Notoginseng 25g and Radix Achyranthis Bidentatae 30g.
Preferably, the Traditional Chinese medicine external medicinal preparation technology of the treatment knee joint osseous arthritis of described improvement includes: take each crude drug in proportion, crosses 100 mesh sieves and makes medicated powder mix homogeneously；Be subsequently adding crude drug weight 4 again to the volumetric concentration of 8 times amount be 50% ethanol, reflux, extract, 2 to 3 times, and by extracting solution concentrating under reduced pressure recycling design, being concentrated into density is 1.0～1.5g/mL；It is eventually adding vaseline that weight ratio is 2:1 and lanoline as substrate, adopts polishing to prepare external application ointment.
Preferably, the external application ointment that the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of described improvement is made is coated on cave, Heding, inside and outside point ex-le 5, and indwelling every day was taken off after 8-10 hour, within every two days, changed once；Within 8 days, be a course for the treatment of, two the course for the treatment of interval 2 days.
The pharmacological action of raw material of Chinese medicine medicine of the present invention is as follows:
Caulis Spatholobi: bitter, sweet, temperature.Return liver, kidney channel；Enrich blood, invigorate blood circulation, dredging collateral.For menoxenia, blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia.
Rhizoma Homalomenae: bitter, pungent, temperature.Return liver, kidney channel.There is the effects such as wind-damp dispelling, relaxing muscles and tendons and activating QI and blood in the collateral, pain relieving, detumescence.Cure mainly rheumatic arthralgia, podomere acid is educated, muscles and bones flaccidity is soft, traumatic injury, stomachache, carbuncle skin ulcer are swollen.
Sanguis Draxonis: heart channel；Liver Channel；Function: dissipating blood stasis analgesic therapy；Hemostasis；Promoting tissue regeneration and ulcer healing；Cure mainly: traumatic injury；Ecchymoma due to internal injury；Dysmenorrhea；Postpartum stagnation is suffered from abdominal pain；Continuous bleeding due to traumatic injury；Scrofula；Ecthyma unhealed for long time and hemorrhoid.
Herba speranskiae tuberculatae: have blood circulation promoting and blood stasis dispelling, diuresis removing toxic substances, deep effect of stimulating the menstrual flow.
Fructus Liquidambaris: bitter in the mouth is flat.Return liver, stomach warp.Function with cure mainly: wind-damp dispelling, the meridian dredging, diuretic, stimulating milk secretion.For rheumatic arthralgia, podomere is numb, spasm of the limbs, edema, dysuria, stagnation of QI-blood, galactostasis, rubella pruritus.
Herba Lycopodii: warm in nature;Return liver, kidney channel;Matter heavily fortified point row dissipates, and drops and can rise;There is strong waist knee joint, wind-damp dispelling, the effect of the gas that reinforces the kidney;Cure mainly lumbago due to renal deficiency ridge strong, foot knee joint weakness, rheumatic arthralgia, the enuresis, frequent micturition, seminal emission, leucorrhea.
The Cortex Eucommiae: invigorating the liver and kidney, bone and muscle strengthening, antiabortive.Controlling spinal column ache, foot and knee flaccidity, dribbling urination, uncontrolled urination is itched, and vaginal bleeding during pregnancy is intended to fall, frequent fetal movement, hypertension.
Rhizoma Chuanxiong: qi-activating drug；Dispel-wind drug；Blood circulation promoting medicine；Blood circulation promoting and blood stasis dispelling；Activating QI to alleviate the depression；Wind-expelling pain-stopping
Olibanum (processed): property acrid, bitter, warm.Enter the heart, liver, spleen channel.Invigorate blood circulation, circulation of qi promoting, pain relieving.Control the epigastric pain of the stasis blocking stagnation of QI, rheumatic arthralgia, traumatic injury, dysmenorrhea, puerperal abdonimal pain.
Myrrha (processed): cure mainly chest and abdomen stasis of blood pain, dysmenorrhea, amenorrhea, abdominal mass, traumatic injury, carbuncle skin infection, acute appendicitis, conjunctival congestion and swelling pain.There is the effect such as promoting blood circulation and stopping pain, detumescence and promoting granulation.
Scolopendra: endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.For infantile convulsion, tic spasm, middle air port is askew, hemiplegia, tetanus, rheumatoid arthritis stubborn, skin infection, scrofula, venom.
Pheretima: salty in the mouth cold in nature.Function: heat clearing away, suppressing the hyperactive liver, Zhichuan, dredging collateral.Cure mainly high fanatical dry, convulsion with spasms, headache due to pathogenic wind-heat, conjunctival congestion, hemiplegia etc.
Scorpio: pungent is flat；Poisonous.Return Liver Channel；Endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.
Flos Carthami: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving.Promoting blood circulation to restore menstrual flow medicine.
Borneolum Syntheticum: logical all keys, dissipates stagnated fire, removing nebula improving eyesight, reducing swelling and alleviating pain.Control apoplexy locked mouth, calentura coma, infantile convulsion expectorant fan, deafness with qi stagnation, sore throat, aphtha, otitis media, carbuncle, hemorrhoid.
Herba Taxilli: bitter；Sweet；Property is put down；Enter liver, kidney channel；Invigorating the liver and kidney；Bone and muscle strengthening；Wind-damp dispelling；Antiabortive.Main soreness of waist and knee joint；Muscles and bones flaccidity is weak；Limbs are hemiplegia；Rheumatic arthralgia；Head is wrong dizzy；Frequent fetal movement, metrostaxis.For rheumatic arthralgia, soreness of the waist and knees, muscles and bones is unable, metrorrhagia through many, blood leaking in gestation, frequent fetal movement；Hypertension.
Radix Notoginseng: there is dissipating blood stasis hemostasis, effect of subduing swelling and relieving pain.Cure mainly spitting of blood, spit blood, epistaxis, to have blood in stool, metrorrhagia, traumatic hemorrhage, chest and abdomen twinge, tumbling down swells and ache.
Radix Achyranthis Bidentatae: blood circulation and stasis-eliminating medicine.Nature and flavor；Bitter；Acid；Property is put down.
Compared with prior art, this formula uses Traditional Chinese Medicine acupoint therapy and modern pharmacy Transdermal absorption theoretical, adopt external application of Chinese medicine acupoint therapy knee joint osseous arthritis, the various teleneurons that can make Skin at Acupoints enter active state, constantly promote the nerve of human body, Humoral immunity effect and immunologic function, improve the functional activity of each internal organs organ, conducted by meridians, QI and blood regulating, thus reaching good therapeutic effect.The Chinese medicine preparation of the present invention clinical tests prove that, there is efficacy stability, not easily recur, clinical efficacy is notable, therapy is easy, quick, safe and reliable, have no side effect, and cost of medical service is cheap, it is adaptable to different medical unit is introduced, promoted, and can be accepted by vast knee osteoarthritis patients.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
The Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight: Caulis Spatholobi 25g, Rhizoma Homalomenae 10g, Sanguis Draxonis 50g, Herba speranskiae tuberculatae 25g, Fructus Liquidambaris 25g, Fructus Chaenomelis 30g, Herba Lycopodii 25g, Cortex Eucommiae 25g, Rhizoma Chuanxiong 25g, Olibanum (processed) 18g, Myrrha (processed) 18g, Scolopendra 13g, Pheretima 10g, Scorpio 9g, Flos Carthami 25g, Borneolum Syntheticum 13g, Herba Taxilli 20g, Radix Notoginseng 18g and Radix Achyranthis Bidentatae 20g.
Embodiment 2
The Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight: Caulis Spatholobi 20g, Rhizoma Homalomenae 5g, Sanguis Draxonis 40g, Herba speranskiae tuberculatae 20g, Fructus Liquidambaris 20g, Fructus Chaenomelis 25g, Herba Lycopodii 20g, Cortex Eucommiae 20g, Rhizoma Chuanxiong 20g, Olibanum (processed) 15g, Myrrha (processed) 15g, Scolopendra 10g, Pheretima 5g, Scorpio 5g, Flos Carthami 20g, Borneolum Syntheticum 10g, Herba Taxilli 15g, Radix Notoginseng 15g and Radix Achyranthis Bidentatae 15g.
Embodiment 3
The Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight: Caulis Spatholobi 30g, Rhizoma Homalomenae 15g, Sanguis Draxonis 60g, Herba speranskiae tuberculatae 30g, Fructus Liquidambaris 30g, Fructus Chaenomelis 35g, Herba Lycopodii 30g, Cortex Eucommiae 30g, Rhizoma Chuanxiong 30g, Olibanum (processed) 25g, Myrrha (processed) 25g, Scolopendra 15g, Pheretima 15g, Scorpio 15g, Flos Carthami 30g, Borneolum Syntheticum 15g, Herba Taxilli 30g, Radix Notoginseng 25g and Radix Achyranthis Bidentatae 30g.
Traditional Chinese medicine external medicinal preparation technology in the embodiment of the present invention includes: take each crude drug in proportion, crosses 100 mesh sieves and makes medicated powder mix homogeneously；Be subsequently adding crude drug weight 4 again to the volumetric concentration of 8 times amount be 50% ethanol, reflux, extract, 2 to 3 times, and by extracting solution concentrating under reduced pressure recycling design, being concentrated into density is 1.0～1.5g/mL；It is eventually adding vaseline that weight ratio is 2:1 and lanoline as substrate, adopts polishing to prepare external application ointment.
External application ointment Traditional Chinese medicine external medicinal in the embodiment of the present invention made is coated on cave, Heding, inside and outside point ex-le 5, and indwelling every day was taken off after 8-10 hour, within every two days, changes once；Within 8 days, be a course for the treatment of, two the course for the treatment of interval 2 days.
Clinical efficacy is verified:
1, physical data
The 150 equal clinical diagnosises of example patient are knee joint osseous arthritis, male 80 examples, female 70 example, age 20-70 year, the course of disease 2 months to 6 years.
2, Therapeutic Method
Take each crude drug in proportion, cross 100 mesh sieves and make medicated powder mix homogeneously；Be subsequently adding crude drug weight 4 again to the volumetric concentration of 8 times amount be 50% ethanol, reflux, extract, 2 to 3 times, and by extracting solution concentrating under reduced pressure recycling design, being concentrated into density is 1.0～1.5g/mL；It is eventually adding vaseline that weight ratio is 2:1 and lanoline as substrate, adopts polishing to prepare external application ointment.
External application ointment Traditional Chinese medicine external medicinal in the embodiment of the present invention made is coated on cave, Heding, inside and outside point ex-le 5, and indwelling every day was taken off after 8-10 hour, within every two days, changes once；Within 8 days, be a course for the treatment of, two the course for the treatment of interval 2 days.
3, therapeutic outcome
Criterion of therapeutical effect: formulate with reference to the criterion of therapeutical effect in " Chinese medical disease Standardization of diagnosis and curative effect ".Cure: transference cure, joint function recovery is normal；Effective: arthralgia substantially alleviates, swelling disappears substantially, and function of joint is obviously improved；Effective: pain, swelling, function of joint take a turn for the better；Invalid: after treatment, symptom, sign and function of joint are unchanged.Treated through 2～4 weeks, cure 50 examples, effective 70 examples, effective 20 examples, invalid 10 examples, total effective rate 93.33%
Clinical test results shows, Drug therapy osteoarthritis of the present invention is evident in efficacy, clinical tests prove that, having efficacy stability, not easily recur, clinical efficacy is notable, therapy is easy, quick, safe and reliable, have no side effect, and cost of medical service is cheap, it is adaptable to different medical unit is introduced, promoted, and can be accepted by vast knee osteoarthritis patients.
Utilize technical solutions according to the invention, or those skilled in the art is under the inspiration of technical solution of the present invention, design similar technical scheme, and reach above-mentioned technique effect, all fall into protection scope of the present invention.
Claims (7)
1. the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis that a kind is improved, it is characterized in that, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of this improvement includes the crude drug of following parts by weight: Caulis Spatholobi 20g～25g, Rhizoma Homalomenae 5g～10g, Sanguis Draxonis 40g～50g, Herba speranskiae tuberculatae 20g～25g, Fructus Liquidambaris 20g～25g, Fructus Chaenomelis 25g～30g, Herba Lycopodii 20g～25g, Cortex Eucommiae 20g～25g, Rhizoma Chuanxiong 20g～25g, Olibanum (processed) 15g～18g, Myrrha (processed) 15g～18g, Scolopendra 10g～13g, Pheretima 5g～10g, Scorpio 5g～9g, Flos Carthami 20g～25g, Borneolum Syntheticum 10g～13g, Herba Taxilli 15g～20g, Radix Notoginseng 15g～18g and Radix Achyranthis Bidentatae 15g～20g.
2. the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis improved as claimed in claim 1, it is characterized in that, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of described improvement includes the crude drug of following parts by weight: Caulis Spatholobi 25g～30g, Rhizoma Homalomenae 10g～15g, Sanguis Draxonis 50g～60g, Herba speranskiae tuberculatae 25g～30g, Fructus Liquidambaris 25g～30g, Fructus Chaenomelis 30g～35g, Herba Lycopodii 25g～30g, Cortex Eucommiae 25g～30g, Rhizoma Chuanxiong 25g～30g, Olibanum (processed) 18g～25g, Myrrha (processed) 18g～25g, Scolopendra 13g～15g, Pheretima 10g～15g, Scorpio 9g～15g, Flos Carthami 25g～30g, Borneolum Syntheticum 13g～15g, Herba Taxilli 20g～30g, Radix Notoginseng 18g～25g and Radix Achyranthis Bidentatae 20g～30g.
3. the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis improved as claimed in claim 1, it is characterized in that, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight: Caulis Spatholobi 25g, Rhizoma Homalomenae 10g, Sanguis Draxonis 50g, Herba speranskiae tuberculatae 25g, Fructus Liquidambaris 25g, Fructus Chaenomelis 30g, Herba Lycopodii 25g, Cortex Eucommiae 25g, Rhizoma Chuanxiong 25g, Olibanum (processed) 18g, Myrrha (processed) 18g, Scolopendra 13g, Pheretima 10g, Scorpio 9g, Flos Carthami 25g, Borneolum Syntheticum 13g, Herba Taxilli 20g, Radix Notoginseng 18g and Radix Achyranthis Bidentatae 20g.
4. the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis improved as claimed in claim 1, it is characterized in that, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight and is: Caulis Spatholobi 20g, Rhizoma Homalomenae 5g, Sanguis Draxonis 40g, Herba speranskiae tuberculatae 20g, Fructus Liquidambaris 20g, Fructus Chaenomelis 25g, Herba Lycopodii 20g, Cortex Eucommiae 20g, Rhizoma Chuanxiong 20g, Olibanum (processed) 15g, Myrrha (processed) 15g, Scolopendra 10g, Pheretima 5g, Scorpio 5g, Flos Carthami 20g, Borneolum Syntheticum 10g, Herba Taxilli 15g, Radix Notoginseng 15g and Radix Achyranthis Bidentatae 15g.
5. the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis improved as claimed in claim 1, it is characterized in that, the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis of a kind of improvement includes the crude drug optimum ratio of following parts by weight and is: Caulis Spatholobi 30g, Rhizoma Homalomenae 15g, Sanguis Draxonis 60g, Herba speranskiae tuberculatae 30g, Fructus Liquidambaris 30g, Fructus Chaenomelis 35g, Herba Lycopodii 30g, Cortex Eucommiae 30g, Rhizoma Chuanxiong 30g, Olibanum (processed) 25g, Myrrha (processed) 25g, Scolopendra 15g, Pheretima 15g, Scorpio 15g, Flos Carthami 30g, Borneolum Syntheticum 15g, Herba Taxilli 30g, Radix Notoginseng 25g and Radix Achyranthis Bidentatae 30g.
6. the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis improved as claimed in claim 1 or 2, it is characterized in that, the Traditional Chinese medicine external medicinal preparation technology of the treatment knee joint osseous arthritis of described improvement includes: take each crude drug in proportion, crosses 100 mesh sieves and makes medicated powder mix homogeneously；Be subsequently adding crude drug weight 4 again to the volumetric concentration of 8 times amount be 50% ethanol, reflux, extract, 2 to 3 times, and by extracting solution concentrating under reduced pressure recycling design, being concentrated into density is 1.0～1.5g/mL；It is eventually adding vaseline that weight ratio is 2:1 and lanoline as substrate, adopts polishing to prepare external application ointment.
7. the Traditional Chinese medicine external medicinal of the treatment knee joint osseous arthritis improved as claimed in claim 6, it is characterised in that described external application ointment is coated on cave, Heding, inside and outside point ex-le 5, and indwelling every day was taken off after 8-10 hour, changes once for every two days；Within 8 days, be a course for the treatment of, two the course for the treatment of interval 2 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610170631.7A CN105708999A (en) | 2016-03-24 | 2016-03-24 | Improved externally-applied traditional Chinese medicine for treating knee joint osteoarthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610170631.7A CN105708999A (en) | 2016-03-24 | 2016-03-24 | Improved externally-applied traditional Chinese medicine for treating knee joint osteoarthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105708999A true CN105708999A (en) | 2016-06-29 |
Family
ID=56158279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610170631.7A Pending CN105708999A (en) | 2016-03-24 | 2016-03-24 | Improved externally-applied traditional Chinese medicine for treating knee joint osteoarthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105708999A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116173130A (en) * | 2023-01-07 | 2023-05-30 | 绵阳市今盛昔健康科技有限公司 | Bone penetrating medicine for treating neck, shoulder, waist and leg pain caused by wind-cold-dampness and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104288410A (en) * | 2014-10-16 | 2015-01-21 | 河南中医学院 | Traditional Chinese medicine ointment for treating knee osteoarthritis |
| CN104324097A (en) * | 2014-10-11 | 2015-02-04 | 长春中医药大学 | Externally-applied traditional Chinese medicine composition for treating pain arthralgia type knee osteoarthritis |
-
2016
- 2016-03-24 CN CN201610170631.7A patent/CN105708999A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104324097A (en) * | 2014-10-11 | 2015-02-04 | 长春中医药大学 | Externally-applied traditional Chinese medicine composition for treating pain arthralgia type knee osteoarthritis |
| CN104288410A (en) * | 2014-10-16 | 2015-01-21 | 河南中医学院 | Traditional Chinese medicine ointment for treating knee osteoarthritis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116173130A (en) * | 2023-01-07 | 2023-05-30 | 绵阳市今盛昔健康科技有限公司 | Bone penetrating medicine for treating neck, shoulder, waist and leg pain caused by wind-cold-dampness and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101391077B (en) | Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN103316146B (en) | Traditional Chinese medicinal preparation for anesthesia | |
| CN102805817B (en) | Medicine for treating rheumatism and rheumatoid diseases | |
| CN111588828A (en) | Chinese medicinal preparation for treating new coronavirus and viral diseases, and its preparation method | |
| CN103223078B (en) | Traditional Chinese medicine used for treating knee osteoarthritis through iontophoresis | |
| CN105708999A (en) | Improved externally-applied traditional Chinese medicine for treating knee joint osteoarthritis | |
| CN102949571A (en) | Medicine for treating chronic osteomyelitis | |
| CN113713011A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN104258285A (en) | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof | |
| CN105561270A (en) | Analgesic Chinese herbal medicine for external application and preparation method thereof | |
| CN105288025A (en) | Chinese medicinal powder for treatment of liver qi stagnancy irregular menstruation and preparation method thereof | |
| CN104491558B (en) | A kind of Chinese medicine patch for treating osteoproliferation and preparation method thereof | |
| CN104352737A (en) | Traditional Chinese medicinal preparation for treating rheumatic low back and leg pain | |
| CN104623227A (en) | Formula for traditional Chinese medicine for treating pain in waist and lower extremities | |
| CN103845583B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis | |
| CN103721183B (en) | A kind of Chinese medicine composition for the treatment of middle-aged and elderly people lumbago and skelalgia | |
| CN101869629B (en) | Traditional Chinese medicine for treating renal calculus | |
| CN106256371A (en) | A kind of Chinese medicine composition treating blood stasis type abdominal mass and preparation method thereof | |
| CN106237026A (en) | A kind of pill medicine treating insufficiency of kidney-YANG and preparation method thereof | |
| CN111375005A (en) | External medicine for treating peripheral blood vessels and peripheral nerves of lower limbs and preparation method thereof | |
| CN105106692A (en) | Traditional Chinese medicinal composition for gallstone postoperative recovery and preparation method of traditional Chinese medicinal composition | |
| CN104740193A (en) | Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition | |
| CN104587399A (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN116920064A (en) | Traditional Chinese medicine formula for treating rheumatic bone diseases and processing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160803 Address after: 450046 Henan city of Zhengzhou province Zheng Dong New District Yongping Road No. 100 (Henan province Luoyang city Chanhe Qiming Road No. 82) Applicant after: Luoyang Orthopedic-Traumatological Hospital Of Henan Province(Henan Provincial Orthopedic Hospital) Address before: 450003 Zhengzhou, Henan Jinshui District No. five weft Road, No. 7 Applicant before: Teng Junyan |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160629 |
|
| RJ01 | Rejection of invention patent application after publication |